BridgeMD
Compares treatment options for Walled Off Pancreatic Necrosis
Official title Nasojejunal Feeding Versus Oral Feeding Following Endoscopic Drainage of Walled Off Pancreatic Necrosis
ClinicalTrials.gov ID: NCT07395778
What this study is testing
- What it's testing
- The goal of this randomized control trial is to assess whether nasojejunal feed is better than oral nutrition in patients who are undergoing endoscopic cystogastrostomy of walled off necrosis following acute pancreatitis. It will also try to answer, the incidence of infections and feed tolerance.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients of acute pancreatitis (AP) with 18-75 years of age
- Patients with symptomatic WON requiring EUS guided transluminal drainage
- Provision of written informed consent
You likely can't join if
- Patients with collection not amenable for EUS guided drainage (distance of WON \>1 cm from the gastrointestinal lumen)
- Known malignancy or immunocompromised state
- Previous upper gastrointestinal(GI) surgery interfering with absorption
- Active GI bleeding
- GI obstruction, ileus or persistent vomiting
- Patients moribund to undergo endoscopic procedure (Glasgow coma scale \<8 or patients on ventilatory support)
See the full eligibility criteria
- Patients of acute pancreatitis (AP) with 18-75 years of age
- Patients with symptomatic WON requiring EUS guided transluminal drainage
- Provision of written informed consent
- Patients with collection not amenable for EUS guided drainage (distance of WON \>1 cm from the gastrointestinal lumen)
- Known malignancy or immunocompromised state
- Previous upper gastrointestinal(GI) surgery interfering with absorption
- Active GI bleeding
- GI obstruction, ileus or persistent vomiting
- Patients moribund to undergo endoscopic procedure (Glasgow coma scale \<8 or patients on ventilatory support)
- Patients with irreversible coagulopathy like platelets \ 1.5
- Pregnant or lactating female
The study team makes the final eligibility decision.
Where it's taking place
- Chandigarh, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chandigarh, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.